The Post-CAR Prognostic Index (PC-PI): A New Prognostic Score to Predict Overall Survival in Large B-Cell Lymphoma Patients Progressing after Chimeric Antigen Receptor T-Cell Therapy

Introduction: Chimeric antigen receptor (CAR) T-cell therapy fails to achieve durable responses in 60% of relapsed/refractory (R/R) large B-cell lymphoma (LBCL) patients in the third or later line setting. There is no standard treatment after CAR T-cell therapy progression and a wide range of outcom...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2023-11, Vol.142 (Supplement 1), p.227-227
Hauptverfasser:	Iacoboni, Gloria, Navarro Garces, Victor, Iraola, Josu, Sesques, Pierre, Rejeski, Kai, Serpenti, Fabio, Bastos-Oreiro, Mariana, Martin Lopez, ANA Africa, Delgado, Javier, Perez, Ariadna, Guerreiro, Manuel, Caballero Gonzalez, Ana Carolina, Martinez-Cibrian, Nuria, Luzardo Henriquez, Hugo Daniel, Sanchez Pina, Jose Maria, Sancho, Juan-Manuel, Ghesquieres, Herve, Mussetti, Alberto, Barba, Pere, Lopez Corral, Lucia, Hernani, Rafael, Reguera, Juan Luis, Sureda Balari, Anna Maria, Bosch, Francesc, Martin Garcia-Sancho, Alejandro, Kwon, Mi, Kuhnl, Andrea, Subklewe, Marion, Bachy, Emmanuel, Villacampa, Guillermo, Abrisqueta Costa, Pau
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!